Two Sigma Investments, LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $560,752 - $799,035	-49,232 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $650,847 - $939,838	49,232 New	49,232 $686,000
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $931,177 - $1.34 Million	-55,826 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $3.25 Million - $4.64 Million	-219,618 Reduced 79.73%	55,826 $986,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $3.11 Million - $5.21 Million	204,219 Added 286.72%	275,444 $4.22 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $790,734 - $1.36 Million	52,436 Added 279.08%	71,225 $1.82 Million
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $6,358 - $11,421	578 Added 3.17%	18,789 $291,000
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $95,425 - $236,014	18,211 New	18,211 $201,000
Q4 2018 Feb 14, 2019	SELL	$16.25 - $28.09 $218,432 - $377,585	-13,442 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.23 - $30.93 $177,837 - $415,761	13,442 New	13,442 $343,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.